Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method
about
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3BThe DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer CellsPhase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation.Demethylating Agents in the Treatment of CancerA new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.Fused-core silica column ultra-performance liquid chromatography-ion trap tandem mass spectrometry for determination of global DNA methylation status.Epigenotoxicity of environmental pollutants evaluated by a combination of DNA methylation inhibition and capillary electrophoresis-laser-induced fluorescence immunoassay.Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia.A sensitive mass spectrometry method for simultaneous quantification of DNA methylation and hydroxymethylation levels in biological samplesPhase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML.Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabineBortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia.DNA methylation determination by liquid chromatography-tandem mass spectrometry using novel biosynthetic [U-15N]deoxycytidine and [U-15N]methyldeoxycytidine internal standards.Modulation of DNA methylation by a sesquiterpene lactone parthenolide.MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.Reactivation of RASSF1A in breast cancer cells by curcuminQuantification of regional DNA methylation by liquid chromatography/tandem mass spectrometry.Casticin inhibits the activity of transcription factor Sp1 and the methylation of RECK in MGC803 gastric cancer cells.Frontiers of mass spectrometry in nucleic acids analysis.Hypomethylation of repeated DNA sequences in cancer.miRNA and methylation: a multifaceted liaison.Modern LC in therapeutic drug monitoring and diagnosis of pediatric leukemia.Epigenetics: A primer for clinicians.Evaluating the global CpG methylation status of native DNA utilizing a bipartite split-luciferase sensor.Curcumin and dimethoxycurcumin induced epigenetic changes in leukemia cells.Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns.Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia.Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.High-throughput and cost-effective global DNA methylation assay by liquid chromatography-mass spectrometry.Epigenetic Regulation of miR-29s Affects the Lactation Activity of Dairy Cow Mammary Epithelial Cells.Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.Global DNA methylation: comparison of enzymatic- and non-enzymatic-based methods.A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target.Fetal Hemoglobin Induction by Epigenetic Drugs
P2860
Q24564757-2B4CF39C-7B95-4A1A-B526-3A081B6C9595Q27313466-F3C3CA3D-65E8-4799-BDB6-B04C6FF14399Q33389485-BEB38351-1124-454E-AD7C-45FF9A3C740BQ33678040-F163315F-1C91-481F-8C08-1CEC27C8179EQ33901844-311F8021-DF13-443C-946C-6CACBBC6DA13Q34433699-C8A463C7-7A0C-44EB-8DF5-26CC4DE633A8Q34573062-A7C27C99-7F17-4CB0-A734-53F4E6EC8F54Q34606426-D3EAE1E0-2AD5-46E7-89ED-AB96E39CB2CCQ34758179-86025698-13B9-4FC0-B2B6-14CD31CC9DFAQ35164242-73A082F7-B822-4DBB-9B2B-E9188CFD46A6Q35750354-269DCE54-86AF-4C0B-A214-89FC89DC3A86Q36445921-03FF1FF2-9EFE-4DFF-BDEB-8A8AB43088ABQ36935381-E0061426-CA31-4267-BAB9-DB49A74A5F74Q37168514-7273A2CB-5301-4EAC-B908-06CC26272A07Q37262433-DEB8DF9D-0B88-46EF-9356-1A0C70AA395AQ37370439-7673EE76-BD84-44E3-B39B-BE2E969F3100Q37610973-C2377632-039D-46EC-B65E-2938B03E29F1Q37697613-967ECF6A-C3CC-4B36-8A84-047AA5670C30Q37763427-88C6F29B-231F-43FE-86CD-EABDA15B28F1Q37961724-BF79F1A1-F887-4735-97ED-0E11D310BF28Q38282163-A35BC0B2-A233-4CF2-9AF7-4D48F7B681C7Q38285133-10D1EFCD-D09D-4079-93BF-8EFDEBD03075Q38770916-E1BF5229-F903-48DD-BBB6-3299B8DCF352Q38913409-34D605A2-6434-4C6D-B414-BB76878E63C4Q38960115-AC19C608-8061-4306-9BEA-A7199B73E558Q39003554-9F0B9B18-2D03-4833-9FAD-DBB38EE43D46Q39181050-865D579A-45B9-4BB2-B93D-DE0E9653C846Q39688414-0574BD89-1AE6-4122-9918-DA1DE7576B88Q40899054-8EE0603D-8A06-4D7A-9A72-77FE2DD4429DQ41471486-E89F8F76-7B4E-4F44-B03E-D14B2FDE736CQ41576877-93047447-E1E9-4B3B-863E-9917B6168867Q42846115-C3C567F0-95F6-40DE-B09D-25411B158E45Q47674218-63A9361B-37CB-4932-8C72-840F686982C3Q57753972-FA8820E9-293D-4C99-A6C3-3D8329E7B12C
P2860
Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Characterization of in vitro a ...... and sensitive LC-MS/MS method
@ast
Characterization of in vitro a ...... and sensitive LC-MS/MS method
@en
type
label
Characterization of in vitro a ...... and sensitive LC-MS/MS method
@ast
Characterization of in vitro a ...... and sensitive LC-MS/MS method
@en
prefLabel
Characterization of in vitro a ...... and sensitive LC-MS/MS method
@ast
Characterization of in vitro a ...... and sensitive LC-MS/MS method
@en
P2093
P2860
P356
P1476
Characterization of in vitro a ...... and sensitive LC-MS/MS method
@en
P2093
Danilo Perrotti
Kenneth K Chan
Peter Paschka
Rebecca Klisovic
Shujun Liu
William Blum
Zhiliang Xie
Zhongfa Liu
P2860
P356
10.1093/NAR/GKL1156
P407
P577
2007-01-30T00:00:00Z